AirSculpt Technologies(AIRS) - 2025 Q4 - Annual Report

Financial Performance - For the year ended December 31, 2025, the company generated $151.8 million in revenue, a decline of approximately 15.8% compared to $180.4 million in 2024[19] - For the year ended December 31, 2025, the company reported approximately $152 million in revenue, a decline of approximately 15.8% compared to $180 million in 2024[34] - Average revenue per case in 2025 was $12,809, with a requirement for 100% private pay upfront, eliminating reimbursement risk[32] - Selling expenses for 2025 were approximately $36.9 million, representing about 24.3% of total revenue[52] - Customer acquisition costs were approximately $3,114 per customer in 2025[52] - Total advertising costs for 2025 were $27.3 million, with approximately 90% allocated to digital advertising[51] Market Dynamics - The addressable market for body fat reduction procedures was estimated to be $11 billion in 2022, with a projected compound annual growth rate of 9% through 2027[20] - The increasing use of weight-loss drugs may lead to higher demand for body contouring and skin tightening procedures, indicating a shift in market dynamics[21] - Increased market acceptance of weight-loss drugs may lead to higher demand for body contouring and skin tightening procedures, although long-term impacts remain uncertain[21] - The company aims to enhance brand awareness and attract new patients, capitalizing on the growing acceptance of body contouring and cosmetic treatments[35] Operational Scale and Innovation - The company performed 11,852 body contouring procedures in 2025, showcasing its operational scale and market presence[18] - The introduction of new procedures, such as AirSculpt + and AirSculpt Smooth, reflects the company's commitment to innovation in body contouring[18] - In fiscal year 2025, the company focused on new product innovation, including the introduction of new services like the skin tightening procedure and the Hip Flip® and CankCure®[35] - The proprietary AirSculpt method allows for minimally invasive fat removal and skin tightening, differentiating the company from traditional procedures[25] - The AirSculpt procedure is designed to be minimally invasive, requiring no needle, scalpel, stitches, or general anesthesia, which differentiates it from traditional liposuction[38] Geographic Presence - The company operates 31 centers across 20 U.S. states and Canada, enhancing its geographical reach and patient access[18] - As of March 31, 2026, the company operates 31 centers across 20 U.S. states and Canada, generating an average revenue per case of $12,809 in 2025[32] - The company aims to expand its footprint with over 200 potential locations identified in North America, although new center openings are currently on hold to improve liquidity[37] - The company’s centers typically range from 3,000 to 5,000 square feet and are staffed by independent surgeons and support personnel, operating six days a week[49] Human Resources and Talent Acquisition - Surgeons at the company are compensated competitively, often earning more than the average full-time salary in private practice, which aids in attracting top talent[30] - The company employs approximately 330 full-time employees and 33 part-time employees, with contracts with about 90 surgeons as of December 31, 2025[74] - Each Professional Association contracts with surgeons, who are paid a percentage of the professional fees collected, typically ranging from 40% to 60%[62] - The company faces competition for high-quality surgeons and professionals in the body contouring and cosmetic surgery industry[64] Compliance and Regulatory Environment - The company has structured its operations to comply with healthcare laws and regulations, but acknowledges potential risks from evolving interpretations of these laws[67] - The company acknowledges the potential impact of regulatory changes on its business structure and operations[67] - The company operates under strict state laws that prohibit non-physicians from practicing medicine, which could impact its operational structure[71] - The company emphasizes the importance of maintaining necessary licenses and accreditations for its centers to operate profitably[69] - The company seeks accreditation from The Joint Commission for all its centers, demonstrating its commitment to safety and quality in patient care[69] Marketing and Customer Engagement - The company plans to optimize marketing investments to enhance efficiency and drive sustainable revenue growth through data-driven insights[53] - The company generated over 625,000 monthly website visits through optimized digital marketing efforts[37] - Approximately 50% of cases in 2025 involved patients securing third-party financing, enhancing affordability and customer accessibility[54] - Approximately 50% of cases in 2025 involved patients securing third-party financing, indicating a focus on expanding consumer financing options[54] Intellectual Property - The company's patent portfolio includes multiple issued and pending patents, underscoring its focus on protecting innovative technologies in body contouring[28] - The company has a patent portfolio consisting of two issued U.S. utility patents and one pending application, with expectations for patents to expire in 2033 or later[55] - The company’s patent portfolio includes two issued U.S. utility patents and several pending applications, supporting its proprietary technology in body contouring[28] Business Structure and Agreements - The company has entered into long-term Management Services Agreements (MSAs) with Professional Associations, typically with an initial term of 10 years, which automatically renew for successive 5-year terms[63] - The company has established Continuity Agreements with Surgeon Owners to ensure operational stability and continuity within its Professional Associations[65] - The company has entered into Continuity Agreements to ensure the stability of Professional Associations, which include provisions for ownership transfer under specific circumstances[65] Company History - The company was founded in 2012 and reorganized in 2018, completing its IPO on October 28, 2021[77]